| Title | Molecular Therapy - Methods and Clinical Development |
| Abbreviation | Mol. Ther. - Methods Clin. Dev. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1) |
| h-index | 60 |
| Overall Rank/Ranking | 1485 |
| SCImago Journal Rank (SJR) | 1.896 |
| Impact Score | 4.54 |
| Publisher | Cell Press |
| Country | United States |
| ISSN | 23290501 |
| Best Quartile | Q1 |
| Coverage History | 2014-2023 |
Molecular Therapy - Methods and Clinical Development is a journal covering the technologies/fields/categories related to Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1). It is published by Cell Press. The overall rank of Molecular Therapy - Methods and Clinical Development is 1485. According to SCImago Journal Rank (SJR), this journal is ranked 1.896. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 60. The best quartile for this journal is Q1.
The ISSN of Molecular Therapy - Methods and Clinical Development journal is 23290501. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Molecular Therapy - Methods and Clinical Development is cited by a total of 3131 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Molecular Therapy - Methods and Clinical Development is 4.54, which is computed in 2024 as per its definition. Molecular Therapy - Methods and Clinical Development IF is decreased by a factor of 0.35 and approximate percentage change is -7.16% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Molecular Therapy - Methods and Clinical Development is 4.54. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.54 |
| 2022 | 4.89 |
| 2021 | 5.87 |
| 2020 | 6.11 |
| 2019 | 4.41 |
| 2018 | 3.94 |
| 2017 | 3.10 |
| 2016 | 2.93 |
| 2015 | 1.85 |
| 2014 | 0.00 |
Molecular Therapy - Methods and Clinical Development has an h-index of 60. It means 60 articles of this journal have more than 60 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Molecular Therapy - Methods and Clinical Development is 23290501. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Molecular Therapy - Methods and Clinical Development is 1485. According to SCImago Journal Rank (SJR), this journal is ranked 1.896. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.896 |
| 2022 | 1.825 |
| 2021 | 1.819 |
| 2020 | 2.285 |
| 2019 | 1.872 |
| 2018 | 1.487 |
| 2017 | 1.311 |
| 2016 | 1.158 |
| 2015 | 0.827 |
| 2014 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1485 |
| 2022 | 1536 |
| 2021 | 1469 |
| 2020 | 1062 |
| 2019 | 1475 |
| 2018 | 2278 |
| 2017 | 2886 |
| 2016 | 3535 |
| 2015 | 5674 |
| 2014 | 32540 |
Molecular Therapy - Methods and Clinical Development is published by Cell Press. It's publishing house is located in United States. Coverage history of this journal is as following: 2014-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Molecular Therapy - Methods and Clinical Development is Mol. Ther. - Methods Clin. Dev.. This abbreviation ('Mol. Ther. - Methods Clin. Dev.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Molecular Therapy - Methods and Clinical Development latest impact IF is 4.54. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.11 (2020) and 0.00 (2014), respectively, in the last 10 years. Moreover, its average IS is 3.76 in the previous 10 years.
The Molecular Therapy - Methods and Clinical Development has an SJR (SCImago Journal Rank) of 1.896, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 2.285 in 2020 and the lowest being in 2014. Furthermore, the average SJR of the Molecular Therapy - Methods and Clinical Development over the previous 10-year period stands at 3.76.
The latest h-index of the Molecular Therapy - Methods and Clinical Development is 60.
The Molecular Therapy - Methods and Clinical Development is published by the Cell Press, with its country of publication being the United States.
The Molecular Therapy - Methods and Clinical Development is currently ranked 1485 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1062 in 2020 and its lowest position of 32540 in 2014.
The standard ISO4 abbreviation for the Molecular Therapy - Methods and Clinical Development is Mol. Ther. - Methods Clin. Dev..
Molecular Therapy - Methods and Clinical Development is classified as a journal that the Cell Press publishes.
The Molecular Therapy - Methods and Clinical Development encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Molecular Therapy - Methods and Clinical Development is assigned the following International Standard Serial Numbers (ISSN): 23290501.
The best quartile for the Molecular Therapy - Methods and Clinical Development is Q1 (2023).
The Molecular Therapy - Methods and Clinical Development coverage history can be summarized as follows: 2014-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Milan Journal of Mathematics | journal | 3538 | Birkhauser Verlag Basel | 29 | 1.14 |
| Journal of Classical Sociology | journal | 15798 | SAGE Publications Ltd | 30 | 1.30 |
| Discourse | journal | 6196 | Routledge | 65 | 2.36 |
| British Journal of Special Education | journal | 16076 | Wiley-Blackwell Publishing Ltd | 44 | 0.78 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 10391 | E. Schweizerbart'sche Verlagsbuchhandlung | 17 | 3.43 |
| Built Environment | journal | 12809 | Alexandrine Press | 46 | 1.18 |
| Proteomics - Clinical Applications | journal | 9438 | Wiley-VCH Verlag | 64 | 2.28 |
| Archiv fur Geflugelkunde | journal | 28770 | Verlag Eugen Ulmer | 30 | 0.00 |
| SPE International Formation Damage Control Symposium Proceedings | conference and proceedings | 21934 | 16 | 0.00 | |
| Rudarsko Geolosko Naftni Zbornik | journal | 13873 | 19 | 1.48 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.54 |
| 2022 | 4.89 |
| 2021 | 5.87 |
| 2020 | 6.11 |
| 2019 | 4.41 |
| 2018 | 3.94 |
| 2017 | 3.10 |
| 2016 | 2.93 |
| 2015 | 1.85 |
| 2014 | 0.00 |
